Benzofuranones as potential antinociceptive agents: Structure-activity relationships

European Journal of Medicinal Chemistry

Volumn 56, Issue , 2012, Pages 120-126

  Gonçalves, Cleiton José ^a   Lenoir, Andrey Sávio ^a   Padaratz, Pâmela ^a   Corrêa, Rogério ^a   Niero, Rivaldo ^a   Cechinel Filho, Valdir ^a   Campos Buzzi, Fátima De ^a  

^a UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

Author keywords

Antinociceptive properties; Benzofuranone; Topliss method

Indexed keywords

3 [2 (3 METHOXYPHENYL) 2 OXOETHYL] 2 BENZOFURAN 1(3H) ONE; 3 [2 (4 CHLOROPHENYL) 2 OXOETHYL] 2 BENZOFURAN 1(3H) ONE; ANTINOCICEPTIVE AGENT; BENZOFURAN DERIVATIVE; FURANONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROPHOBICITY; HYPERALGESIA; MALE; MOUSE; NEUROPATHIC PAIN; NONHUMAN; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; BENZOFURANS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MOLECULAR STRUCTURE; PAIN; PAIN MEASUREMENT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84865761192     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2012.08.015     Document Type: Article

References (36)

1. R. Corrêa, M.A.S. Pereira, D. Buffon, L. Santos, V. Cechinel-Filho, A.R.S. Santos, and R.J. Nunes Antinociceptive properties of chalcones. Structure-activity relationships Arch. Pharm. 334 2001 332 334
2. F. Campos-Buzzi, J.P. Campos, P.P. Tonini, R. Corrêa, R.A. Yunes, P. Boeck, and V. Cechinel-Filho Antinociceptive effects of synthetic chalcones obtained from xanthoxyline Arch. Pharm. 339 2006 361 365
3. Z. Nowakowska A review of anti-infective and anti-inflammatory chalcones Eur. J. Med. Chem. 42 2007 125 137
4. M. Cabrera, M. Simoens, G. Falchi, M.L. Lavaggi, O.E. Piro, E.E. Castellano, A. Vidal, A. Azqueta, A. Monge, A.L. de Ceráin, G. Sagrera, G. Seoane, H. Cerecetto, and M. González Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships Bioorg. Med. Chem. 15 2007 3356 3367
5. D. Batovska, S. Parushev, A. Slavova, V. Bankova, I. Tsvetkova, M. Ninova, and H. Najdenski Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans Eur. J. Med. Chem. 42 2007 87 92
6. P. Boeck, B. Falcão, P.C. Leal, R.A. Yunes, V. Cechinel-Filho, E.C. Torres-Santos, and B. Rossi-Bergmann Synthesis of chalcone analogues with increased antileishmanial activity Bioorg. Med. Chem. 14 2006 1538 1545
7. C. Kontogiorgis, M. Mantzanidou, and D. Hadjipavlou-Litina Chalcones and their potential role in inflammation Mini Rev. Med. Chem. 8 2008 1224 1242
8. A.M. Katsori, and D. Hadjipavlou-Litina Chalcones in cancer: understanding their role in terms of QSAR Curr. Med. Chem. 16 2009 1062 1081
9. A.M. Katsori, and D. Hadjipavlou-Litina Recent progress in therapeutic applications of chalcones Expert Opin. Ther. Pat. 21 2011 1575 1596
10. J.R. Dimmock, D.W. Elias, M.A. Beazely, and N.M. Kandepu Bioactivities of chalcones Curr. Med. Chem. 6 1999 1125 1149
11. L. Ni, Q.M. Meng, and J.A. Siroski Recent advances in therapeutic chalcones Expert Opin. Ther. 14 2004 1669 1691
12. K. Terasawa, Y. Sugita, I. Yokoe, S. Fujisawa, and H. Sakagami Cytotoxic activity of 2-aminomethylene-3(2H)-benzofuranones against human oral tumor cell lines Anticancer Res. 21 2001 3371 3375
13. N. Hadj-esfandiari, L. Navidpour, H. Shadnia, M. Amini, N. Samadi, M.A. Faramarzi, and A. Shafie Synthesis, antibacterial activity, and quantitative structure-activity relationships of new (Z)-2-(nitroimidazolylmethylene)-3(2H)- benzofuranone derivatives Bioorg. Med. Chem. Lett. 17 2007 6354 6363
14. P. Padaratz, M. Fracasso, F. Campos-Buzzi, R. Corrêa, R. Niero, F. Delle Monache, and V. Cechinel-Filho Antinociceptive activity of a new benzofuranone derived from a chalcone Basic Clin. Pharmacol. Toxicol. 105 2009 257 261
15. X.Q. Zhu, J. Zhou, C.H. Wang, X.T. Li, and S. Jing Actual structure, thermodynamic driving force, and mechanism of benzofuranone-typical compounds as antioxidants in solution J. Phys. Chem. B 115 2011 3588 3603
16. T.B. Schnaide, and C. de Souza Aspectos éticos da experimentação animal Rev. Bras. Anestesiol. 53 2003 278 285
17. H.D.J. Collier, L.C. Dinneen, C.A. Johnson, and C. Schneider The abdominal constriction response and its suppression by analgesic drugs in the mouse Br. J. Pharmacol. 32 1968 295 310
18. S. Hunskaar, O.B. Fasmer, and K. Hole Formalin test in mice, a useful technique for evaluating mild analgesics J. Neurosci. Methods 14 1985 69 76
19. A. Tjolsen, O.G. Berge, S. Hunskaar, J.H. Rosland, and K. Hole The formalin test: an evaluation of the method Pain 51 1992 5 17
20. T. Sakurada, K. Katsumata, K. Tan-No, S. Sakurada, and K. Kisara The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord Neuropharmacology 31 1992 1279 1285
21. A. Beirith, A.R.S. Santos, and J.B. Calixto Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw Brain Res. 924 2002 219 228
22. N.B. Eddy, and D. Leimback Synthetic analgesics. II. Dithienylbutenyl and dithienylbutilamines J. Pharmacol. Exp. Ther. 107 1953 385 393
23. D.Y. Lee, C.S. Cho, L.H. Jiang, X. Wu, S.C. Shim, and D.H. Oh Palladium-Catalysed synthesis of 3-alkylphtalides via carbonylative cyclization of o-bromo-benzaldehyde with 1,3-dicarbonyl compounds Syn. Commun. 27 1997 3449 3455
24. M.V. Paradkar, S.Y. Gadre, T.A. Pujari, P.P. Khandekar, and V.B. Kumbhar One-pot synthesis of 3-phenacylphthalides Syn. Commun. 35 2005 471 474
25. C. Meyre-Silva, R.A. Yunes, V. Schlemper, F. Campos-Buzzi, and V. Cechinel Filho Analgesic potential of marrubiin derivatives, a diterpene present in Marrubium vulgare (Lamiaceae) Il Fármaco 60 2005 321 326
26. M. Shibata, T. Okhubo, H. Takahashi, and R. Inoki Modified formalin test: characteristics biphasic pain response Pain 38 1989 346
27. S. Hunskaar, and K. Hole The formalin test in mice: dissociation between inflammatory and non-inflammatory Pain 30 1987 103
28. J.H. Rosland, A. Tjolsen, B. Machle, and K. Hole The formalin test in mice, effect of formalin concentration Pain 42 1990 235
29. Q. Lin, X. Zou, Y. Ren, J. Wang, L. Fang, and D. Willis Involvement of peripheral neuropeptide y receptors in sympathetic modulation of acute cutaneous flare induced by intradermal capsaicin Neuroscience 123 2004 337 347
30. http://www.molinspiration.com/cgi-bin/properties
31. C.L. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Del. Rev. 46 2001 3 26
32. http://preadmet.bmdrc.org/preadmet/index.php
33. A.P. Beresford, H.E. Selick, and M.H. Tarbit The emerging importance of predictive ADME simulation in drug discovery Drug Discov. Today 7 2002 109 116
34. P. Ertl, B. Rohde, and P. Selzer Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties J. Med. Chem. 43 2000 3714 3717
35. S. Yee In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth Pharm. Res. 14 1997 763 766
36. X. Ma, C. Chen, and J. Yang Predictive model of blood-brain barrier penetration of organic compounds Acta Pharmacol. Sínica 26 2005 500 512